Abstract:Electrocardiography (ECG) is one of the most widely used tests for diagnosing cardiovascular disease. Yet several remote clinics still utilize paper ECG printouts for their analysis due to limited connectivity and computational capacity. As a result, vast numbers of physical ECGs obtained in remote areas still remain incapable of being accessed by contemporary artificial-intelligence (AI)-based decision support as they require high computational resources or strong high-speed internet connectivity. This causes several cases where conditions like acute coronary occlusion (ACS) is overlooked and reperfusion therapy delayed. Although prior work has tackled digitization and diagnosis separately, and utilized advanced AI models for them, there still remains a lack of a compute-light, on-device framework that reconstructs paper ECGs at high fidelity, while accurately supporting multiple clinically relevant endpoints. We address this need with an end-to-end lightweight on-device digitization-to-diagnosis pipeline that converts a smartphone photo or scan of a paper ECG into a calibrated 12-lead signal and screens for Myocardial Infarction (MI) pathologies, with SHapley Additive exPlanations (SHAP) to support interpretability. Trained and evaluated on 21,799 ECGs from the PTB-XL dataset and further validated on hospital-acquired ECG-Matrix dataset, the complete system runs in <30 s per ECG on CPU-only resources, achieving 95.51% accuracy (F1 = 0.9519) for MI detection on PTB-XL and 88.89% accuracy (F1 = 0.8862) for OMI detection on ECG-Matrix. This work showcases that legacy paper records can be reliably democratized in any part of the world, providing a scalable decision support when digital ECG export, connectivity, or high-end compute are unavailable
Abstract:Public health intervention techniques have been highly significant in reducing the negative impact of several epidemics and pandemics. Among all of the wide-spread diseases, one of the most dangerous one has been severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or Coronavirus disease 2019 (COVID-19). The impact of the virus has been observed in over 200 countries leading to hospitalizations and deaths of millions of people. Currently existing COVID-19 risk estimation tools provided to the general public have been highly variable during the pandemic due to its dependency on rapidly evolving factors such as community transmission levels and variants. There has also been confusion surrounding certain personal protective strategies such as risk reduction by mask-wearing and vaccination. In order to create a simplified easy-to-use tool for estimating different individual risks associated with carrying out daily-life activity, we developed COVID-19 Activity Risk Calculator (CovARC). CovARC serves as a gamified public health intervention as users can "play with" how different risks associated with COVID-19 would change depending on several different factors when carrying out a daily routine activity. Empowering the public to make informed, data-driven decisions about safely engaging in activities may help to reduce COVID- 19 levels in the community. In this study, we demonstrate a streamlined, scalable and accurate COVID-19 risk calculation system. Our study also showcases quantitatively, the increased impact of interventions such as vaccination and mask-wearing when cases are higher, which could prove as a validity to inform and support policy decisions around mask mandate case thresholds and other non-pharmaceutical interventions.